Sectra AB (CHIX:SECTBS) 1-Year Sharpe Ratio: -0.42 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:SECTBS Sectra AB CHIX:SECTBS
98 GF Score
Price kr277.30
GF Value kr310.37
Valuation Modestly Undervalued
View Full Analysis

What is Sectra AB 1-Year Sharpe Ratio?

Sectra AB CHIX:SECTBS 98 1-Year Sharpe Ratio is -0.42 as of Jul. 18, 2026. GuruFocus rates CHIX:SECTBS with a GF Score™ of 98/100 and a GF Value™ of kr310.37 (Modestly Undervalued).

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-18), Sectra AB's 1-Year Sharpe Ratio is -0.42.

Sectra AB  (CHIX:SECTBs) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Sectra AB 1-Year Sharpe Ratio Related Terms

CHIX:SECTBS vs ABT, SYK, MDT: 1-Year Sharpe Ratio Comparison

For the Medical Devices subindustry, Sectra AB's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sectra AB 1-Year Sharpe Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Sectra AB's 1-Year Sharpe Ratio falls into.


CHIX:SECTBS
98GF Score
Sectra AB CHIX:SECTBS
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sectra AB 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.42 mean?
Sectra AB (CHIX:SECTBS) has a 1-Year Sharpe Ratio of -0.42 as of Jul. 18, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Sectra AB and its competitors.
Is Sectra AB's 1-Year Sharpe Ratio too high?
Sectra AB's current 1-Year Sharpe Ratio is -0.42. Overall, Sectra AB has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's 1-Year Sharpe Ratio compare to ABT and SYK?
Sectra AB's 1-Year Sharpe Ratio of -0.42 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Devices & Instruments company?
A good 1-Year Sharpe Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Sectra AB and its competitors. Sectra AB's current 1-Year Sharpe Ratio is -0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (CHIX:SECTBS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr310.37, compared to a current price of kr277.30 — trading 10.7% below its estimated fair value. The current 1-Year Sharpe Ratio is -0.42. Sectra AB's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Sectra AB (CHIX:SECTBS), the current 1-Year Sharpe Ratio is -0.42 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sectra AB (CHIX:SECTBS) Overvalued in 2026?

Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued. The current stock price of kr277.30 is trading 10.7% below its estimated GF Value™ of kr310.37. GuruFocus considers Sectra AB to be Modestly Undervalued.

Key valuation signals for CHIX:SECTBS:

  • 1-Year Sharpe Ratio: -0.42
  • GF Value™: kr310.37 vs. price of kr277.30 (10.7% below fair value)
  • GF Score™: 98/100

No single metric tells the full story. See the CHIX:SECTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sectra AB Business Description

Address Teknikringen 20, Linkoping, SWE, 583 30
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
98GF Score

Get the complete analysis for CHIX:SECTBS

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr277.30
Price
kr310.37
GF Value